We will share our expertise in translational neurotechnology, AI and market access for medical technologies
TECNALIA will be taking part in the seminar “Neurotechnology, Artificial Intelligence and Neurology: Translational Neurotechnology", which will be part of the 78th Annual Meeting of the Spanish Society of Neurology (SEN), one of the leading scientific and clinical conferences in the field of neurology in Spain, which will be held from 17th to 21st November 2026 in Seville.
This seminar will bring together researchers, neurologists, technologists and healthcare professionals to analyse the role of new technologies in the prevention, diagnosis, monitoring and treatment of neurological diseases, as well as the challenges involved in translating research into clinical practice and to the market.
Leaders in neurotechnology and medical technologies
TECNALIA will play a key role thanks to two leading experts in neurotechnology and advanced medical technologies.
- Dr Ander Ramos, , Leader of Neurotechnology and Translational Science at TECNALIA and the University of Tübingen, will present “From the laboratory to the patient: translational neurotechnology”. "What we do at TECNALIA", in which he will present the centre’s capabilities and developments in neuroscientific technologies aimed at making a real impact on patients and healthcare professionals.
- During his presentation, he will demonstrate how TECNALIA drives the transfer of knowledge from research to applied solutions in fields such as brain-computer interfaces, neurostimulation systems, rehabilitation technologies, advanced monitoring and artificial intelligence-based tools for neurology.
- Javier González Lodoso, Head of Strategic Initiatives in Health at TECNALIA, will present”R&D and market access. "How we do it at TECNALIA", focusing on strategies that transform scientific advances into healthcare products and services with a real potential to reach the market and generate value for patients, healthcare professionals and businesses.
A comprehensive partner for the development of Smart Medical Devices and neurotechnologies
Participation in this seminar highlights TECNALIA’s position as one of Europe’s leading players in the development of Smart Medical Devices, neurotechnologies and advanced medical technologies, supporting companies, start-ups, hospitals and healthcare organisations throughout the entire innovation cycle.
Our value proposal combines technological, scientific, regulatory and business capabilities to accelerate the development of innovative healthcare solutions, from initial conception through to validation and commercialisation.
- Neurotechnologies for diagnosis, monitoring and neurological rehabilitation.
- Advanced human-technology interfaces.
- Smart clinical decision support systems based on artificial intelligence.
- Connected medical devices and digital healthcare solutions.
- Development and validation of Smart Medical Devices.
- Clinical and regulatory assessment of medical devices.
- Strategies for technology transfer and market access.
Connecting science, technology and clinical impact
TECNALIA’s participation in this forum reflects our commitment to healthcare innovation that can transform scientific knowledge into solutions that improve people’s quality of life.
By combining scientific excellence, unique technological capabilities and a strong market focus, TECNALIA contributes towards the development of the next generation of medical and neurotechnological technologies, driving the development of more precise, personalised and accessible neurology.
- Please contact our team if you would like further information.